Neonatale Cholestase

  • Michael Melter
  • Claus Petersen
  • Ekkehard Sturm


Die Inzidenz der NC wird auf 1 : 2500 Neugeborene geschätzt. Dies entspricht jährlich ca. 300 Erkrankungsfällen in Deutschland.


Literatur zu Abschn. 16.1

  1. Altman RP, Abramson S (1985) Potential errors in the diagnosis and surgical management of neonatal jaundice. J Pediatr Surg 20: 529–534PubMedCrossRefGoogle Scholar
  2. Crofts DJ, Michel VJ, Rigby AS, Tanner MS, Hall DM, Bonham JR (1999) Assessment of stool colour in community management of prolonged jaundice in infancy. Acta Paediatr 88: 969–974PubMedCrossRefGoogle Scholar
  3. Desmet V (2001) The cholangiopathies. In: Suchy FJ, Sokol RJ, Balistreri WF (eds) Liver disease in children, Lippincott Williams & Wilkins, Philadelphia, pp 39–62Google Scholar
  4. Deutsch GH, Sokol RJ, Stathos TH, Knisely AS (2001) Proliferation to paucity: evolution of bile duct abnormalities in a case of Alagille syndrome. Pediatr Dev Pathol 4: 559–563PubMedCrossRefGoogle Scholar
  5. Fung KP, Lau SP (1990) Differentiation between extrahepatic and intrahepatic cholestasis by discriminant analysis. J Paediatr Child Health 26: 132–135PubMedCrossRefGoogle Scholar
  6. Keil S, Vermehren J, Grothues D et al. (2011) Massenspektrometrische Analyse von Serumgallensäuren in der Differentialdiagnostik (cholestatischer) Lebererkrankungen. Monatsschrift Kinderheilkunde 159: 272Google Scholar
  7. Lang T, Knoppke B, Grothues D et al. (2009) ERCP im Kindes-/Jugendalter: Erfahrungen in einem kindergastroenterologischen Zentrum. Klin Paediatr 221: 101Google Scholar
  8. Liu C, Aronow BJ, Jegga AG et al. (2007) Novel resequencing chip customized to diagnose mutations in patients with inherited syndromes of intrahepatic cholestasis. Gastroenterology 132: 119–126PubMedCrossRefGoogle Scholar
  9. Melter M (2010) Endoskopische retrograde Cholangio-Pankreatographie (ERCP). In: Behrens R (Hrsg) Endoskopie in der pädiatrischen Gastroenterologie – Lehrbuch und Atlas. Nutricia, Erlangen, S 276–296Google Scholar
  10. Melter M, Knoppke B, GrothuesD, Schneble F (2010) Leber, Gallenwegsystem. In: Feldkamp A, Resch A (Hrsg) Pädiatrische Ultraschalldiagnostik. Ecomed, Heildelberg, S 1–36Google Scholar
  11. Norton KI, Glass RB, Kogan D et al. (2002) MR cholangiography in the evaluation of neonatal cholestasis: initial results. Radiology 222: 687–691PubMedCrossRefGoogle Scholar
  12. Sokol RJ, Mack C, Narkewicz MR, Karrer FM (2003) Pathogenesis and outcome of biliary atresia: current concepts. J Pediatr Gastroenterol Nutr 37: 4–21PubMedCrossRefGoogle Scholar
  13. Wildhaber BE, McLin VA (2010) Schweizerisches Screeningprogramm für Gallengangatresie. Schweiz Med Forum 10: 480–482Google Scholar

Literatur zu Abschn. 16.2

  1. Chardot C, Carton M, Spire-Bendelac N et al. (1999) Prognosis of biliary atresia in the era of liver transplantation: French national study from 1986 to 1996. Hepatology 30: 606–611PubMedCrossRefGoogle Scholar
  2. Davenport M, Puricelli V, Farrant P et al. (2004) The outcome of the older (> or = 100 days) infant with biliary atresia. J Pediatr Surg 39: 575–581PubMedCrossRefGoogle Scholar
  3. Hartley JL, Davenport M, Kelly DA (2009) Biliary atresia. Lancet 374(9702): 1704–1713PubMedCrossRefGoogle Scholar
  4. Davenport M, Stringer MD, Tizzard SA et al. (2007) Randomized, double-blind, placebo-controlled trial of corticosteroids after Kasai portoenterostomy for biliary atresia. Hepatology46(6): 1821–1827PubMedCrossRefGoogle Scholar
  5. Davenport M, Ong E, Sharif K et al. (2011) Biliary atresia in England and Wales: results of centralization and new benchmark. J Pediatr Surg 46(9): 1689–1694PubMedCrossRefGoogle Scholar
  6. Grabhorn E, Schulz A, Helmke K et al. (2004) Short- and long-term results of liver transplantation in infants aged less than 6 months. Transplantation 78: 2341–2352Google Scholar
  7. Nio M, Ohi R, Miyano T et al. (2003) Five- and 10-year survival rates after surgery for biliary atresia: a report from the Japanese Biliary Atresia Registry. J Pediatr Surg 38: 997–1000PubMedCrossRefGoogle Scholar
  8. Perlmutter DH, Shepherd RW (2002) Extrahepatic biliary atresia: a disease or a phenotype? Hepatology 35: 297–304CrossRefGoogle Scholar
  9. Petersen C (2004) Surgery in biliary atresia – futile or futuristic? Eur J Pediatr Surg 14: 226–229PubMedCrossRefGoogle Scholar
  10. Petersen C (2006) Pathogenesis and treatment opportunities for biliary atresia. Clin Liver Dis 10: 73–88PubMedCrossRefGoogle Scholar
  11. Petersen C, Harder D, Melter M et al. (2008) Postoperative high-dose steroids do not improve mid-term survival with native liver in biliary atresia. Am J Gastroenterol 103(3): 712–719PubMedCrossRefGoogle Scholar
  12. Reuben A (2003) The sensei of Sendai: correcting the uncorrectable. Hepatology 37: 952–955PubMedCrossRefGoogle Scholar
  13. Sokol RJ, Mack C, Narkewicz MR, Karrer FM (2003) Pathogenesis and outcome of biliary atresia: current concepts. J Pediatr Gastroenterol Nutr 37: 4–21PubMedCrossRefGoogle Scholar

Literatur zu Abschn. 16.3

  1. Arnell H, Papadogiannakis N et al. (2010) Follow-up in children with progressive familial intrahepatic cholestasis after partial external biliary diversion. J Pediatr Gastroenterol Nutr 51(4): 494–499PubMedCrossRefGoogle Scholar
  2. Colliton RP, Bason L, Lu FM et al. (2001) Mutation analysis of Jagged1 (JAG1) in Alagille syndrome patients. Hum Mutat 17(2): 151–152PubMedCrossRefGoogle Scholar
  3. Emond JC, Whitington PF (1995) Selective surgical management of progressive familial intrahepatic cholestasis (Byler’s disease). J Pediatr Surg 30(12): 1635–1641PubMedCrossRefGoogle Scholar
  4. Jacquemin E, Hermans D, Myara A et al. (2001) Ursodeoxycholic acid therapy in pediatric patients with progressive familial intrahepatic cholestasis. Hepatology 25(3): 519–523CrossRefGoogle Scholar
  5. Jansen PL, Strautnieks SS, Jacquemin E et al. (1999) Hepatocanalicular bile salt export pump deficiency in patients with progressive familial intrahepatic cholestasis. Gastroenterology 117(6): 1370–1379PubMedCrossRefGoogle Scholar
  6. Jansen PL, Muller M, Sturm E (2001) Genes and cholestasis. Hepatology 34: 1067–1074PubMedCrossRefGoogle Scholar
  7. Kamath BM, Loomes KM, Oakey RJ et al. (2002) Facial features in Alagille syndrome: specific or cholestasis facies? Am J Med Genet 112(2): 163–170PubMedCrossRefGoogle Scholar
  8. Kamath BM, Spinner NB, Emerick KM et al. (2004) Vascular anomalies in Alagille syndrome: a significant cause of morbidity and mortality. Circulation 109(11): 1354–1358PubMedCrossRefGoogle Scholar
  9. Kasahara M, Kiuchi T, Inomata Y et al. (2003) Living-related liver transplantation for Alagille syndrome. Transplantation 75(12): 2147–2150PubMedCrossRefGoogle Scholar
  10. Kaye AJ, Rand EB, et al (2010) Effect of Kasai procedure on hepatic outcome in Alagille syndrome. J Pediatr Gastroenterol Nutr 51(3): 319–321PubMedGoogle Scholar
  11. Klomp LW, Vargas JC, van Mil SW et al. (2004) Characterization of mutations in ATP8B1 associated with hereditary cholestasis. Hepatology 40(1): 27–38PubMedCrossRefGoogle Scholar
  12. Lykavieris P, Crosnier C, Trichet C, Meunier-Rotival M, Hadchouel M (2003) Bleeding tendency in children with Alagille syndrome. Pediatrics 111(1): 167–170PubMedCrossRefGoogle Scholar
  13. Pawlikowska L, Strautnieks S et al (2010) Differences in presentation and progression between severe FIC1 and BSEP deficiencies. J Hepatol 53(1): 170–178PubMedCrossRefGoogle Scholar
  14. Piccoli DA, Spinner NB (2001) Alagille syndrome and the Jagged1 gene. Semin Liver Dis 21(4): 525–534PubMedCrossRefGoogle Scholar
  15. Stapelbroek JM, Peters TA et al (2009) ATP8B1 is essential for maintaining normal hearing. Proc Natl Acad Sci U S A 106(24): 9709–9714PubMedCrossRefGoogle Scholar
  16. Strautnieks SS, Bull LN, Knisely AS et al. (1998) A gene encoding a liver-specific ABC transporter is mutated in progressive familial intrahepatic cholestasis. Nat Genet 20(3): 233–238PubMedCrossRefGoogle Scholar
  17. de Vree JM, Jacquemin E, Sturm E et al. (1998) Mutations in the MDR3 gene cause progressive familial intrahepatic cholestasis. Proc Natl Acad Sci USA 95(1): 282–287PubMedCrossRefGoogle Scholar

Literatur zu Abschn. 16.4

  1. Balistreri WF, Kader HH, Ryckman FC, Heubi JE, Setchell KDR, UDCA Study Group (1992) Ursodeoxycholic acid therapy in paediatric patients with chronic cholestasis. In: Lentze M, Reichen R (eds) Paediatric cholestasis – novel approaches to treatment. Kluwer, Dordrecht, pp 333–343Google Scholar
  2. Bergasa NV (2005) The pruritus of cholestasis. J Hepatol 43: 1078–1088PubMedCrossRefGoogle Scholar
  3. Bergasa NV, Jones EA (1995) The pruritus of cholestasis: potential pathogenic and therapeutic implications of opioids. Gastroenterology 108: 1582–1588PubMedCrossRefGoogle Scholar
  4. Bergasa NV, Alling DW, Talbot TL, Wells MC, Jones EA (1999) Oral nalmefene therapy reduces scratching activity due to the pruritus of cholestasis: a controlled study. J Am Acad Dermatol 41: 431–434PubMedCrossRefGoogle Scholar
  5. Bergasa NV, Mehlman JK, Jones EA (2000) Pruritus and fatigue in primary biliary cirrhosis. Baillieres Best Pract Res Clin Gastroenterol 14: 643–655PubMedCrossRefGoogle Scholar
  6. Beuers U, Gerken G, Pusl T (2006) Biliary drainage transiently relieves intractable pruritus in primary biliary cirrhosis. Hepatology 44: 280–281PubMedCrossRefGoogle Scholar
  7. Borgeat A, Wilder-Smith OH, Mentha G (1993) Subhypnotic doses of propofol relieve pruritus associated with liver disease. Gastroenterology 104: 244–247PubMedGoogle Scholar
  8. Caestecker JS de, Jazrawi RP, Petroni ML, Northfield TC (1991) Ursodeoxycholic acid in chronic liver disease. Gut 32: 1061–1065PubMedCrossRefGoogle Scholar
  9. Cotting J, Lentze MJ, Reichen J (1990) Effects of ursodeoxycholic acid treatment on nutrition and liver function in patients with cystic fibrosis and longstanding cholestasis. Gut 31: 918–921PubMedCrossRefGoogle Scholar
  10. Ghent CN (1987) Pruritus of cholestasis is related to effects of bile salts on the liver, not the skin. Am. J. Gastroenterol. 82: 117–118PubMedGoogle Scholar
  11. Heuman DM (1993) Hepatoprotective properties of ursodeoxycholic acid. Gastroenterology 104: 1865–1870PubMedGoogle Scholar
  12. Hollands CM, Rivera-Pedrogo FJ, Gonzalez-Vallina R et al. (1998) Ileal exclusion for Byler's disease: an alternative surgical approach with promising early results for pruritus. J Pediatr Surg 33: 220–224PubMedCrossRefGoogle Scholar
  13. Jacquemin E, Hermans D, MyaraA et al. (1997) Ursodeoxycholic acid therapy in pediatric patients with progressive familial intrahepatic cholestasis. Hepatology 25: 519–523PubMedCrossRefGoogle Scholar
  14. Jones EA, Bergasa NV (1990) The pruritus of cholestasis: from bile acids to opiate agonists. Hepatology 11: 884–887PubMedCrossRefGoogle Scholar
  15. Jones EA, Bergasa NV (1999) The pruritus of cholestasis. Hepatology 29: 1003–1006PubMedCrossRefGoogle Scholar
  16. Jones EA, Bergasa NV (2000) Evolving concepts of the pathogenesis and treatment of the pruritus of cholestasis. Can J Gastroenterol 14: 33–40PubMedGoogle Scholar
  17. Kardorff R, Melter M, Rodeck B, Brodehl J (1996) Langfristige Ursodeoxycholsäurebehandlung cholestatischer Lebererkrankungen des Kindesalters – klinische und biochemische Effekte. [Long-term ursodeoxycholic acid treatment of cholestatic liver diseases in childhood – clinical and biochemical effects]. Klin Pädiatr 208: 118–122PubMedCrossRefGoogle Scholar
  18. Kirby J, Heaton KW, Burton JL (1974) Pruritic effect of bile salts. Br Med J 4: 693–695PubMedCrossRefGoogle Scholar
  19. Kremer AE, Beuers U, Oude-Elferink RP, Pusl T (2008) Pathogenesis and treatment of pruritus in cholestasis. Drugs 68: 2163–2182PubMedCrossRefGoogle Scholar
  20. Lucey MR, Neuberger JM, Williams R (1986) Primary biliary cirrhosis in men. Gut 27: 1373–1376PubMedCrossRefGoogle Scholar
  21. Melter M, Rodeck B, Kardorff R et al. (2000) Progressive familial intrahepatic cholestasis: partial biliary diversion normalizes serum lipids and improves growth in noncirrhotic patients. Am J Gastroenterol 95: 3522–3528PubMedCrossRefGoogle Scholar
  22. Muller C, Pongratz S, Pidlich J et al. (1998) Treatment of pruritus in chronic liver disease with the 5-hydroxytryptamine receptor type 3 antagonist ondansetron: a randomized, placebo-controlled, double-blind cross-over trial. Eur J Gastroenterol Hepatol 10: 865–870PubMedCrossRefGoogle Scholar
  23. Neff GW, O'Brien CB, Reddy KR et al. (2002) Preliminary observation with dronabinol in patients with intractable pruritus secondary to cholestatic liver disease. Am J Gastroenterol 97: 2117–2119PubMedCrossRefGoogle Scholar
  24. Oelberg DG, Lester R (1986) Cellular mechanisms of cholestasis. Annu Rev Med 37: 297–317PubMedCrossRefGoogle Scholar
  25. Rebhandl W, Felberbauer FX, Turnbull J et al. (1999) Biliary diversion by use of the appendix (cholecystoappendicostomy) in progressive familial intrahepatic cholestasis. J Pediatr Gastroenterol Nutr 28: 217–219PubMedCrossRefGoogle Scholar
  26. Riikonen S, Savonius H, Gylling H et al. (2000) Oral guar gum, a gel-forming dietary fiber relieves pruritus in intrahepatic cholestasis of pregnancy. Acta Obstet Gynecol Scand 79: 260–264PubMedCrossRefGoogle Scholar
  27. Rust C, Sauter GH, Oswald M et al. (2000) Effect of cholestyramine on bile acid pattern and synthesis during administration of ursodeoxycholic acid in man. Eur J Clin Invest 30: 135–139PubMedCrossRefGoogle Scholar
  28. Stander S, Weisshaar E, Mettang T et al. (2007) Clinical classification of itch: a position paper of the International Forum for the Study of Itch. Acta Derm Venereol 87: 291–294PubMedCrossRefGoogle Scholar
  29. Swain MG (1999) Pruritus and lethargy in the primary biliary cirrhosis patient. In: Neuberger J (ed) Primary biliary cirrhosis, West End Studios, Eastbourne, pp 75–81Google Scholar
  30. Whitington PF, Whitington GL (1988) Partial external diversion of bile for the treatment of intractable pruritus associated with intrahepatic cholestasis. Gastroenterol 95: 130–136Google Scholar
  31. Yerushalmi B, Sokol RJ, Narkewicz MR, Smith D, Karrer FM (1999) Use of rifampin for severe pruritus in children with chronic cholestasis. J Pediatr Gastroenterol Nutr 29: 442–447PubMedCrossRefGoogle Scholar
  32. Yoshikawa M, Tsujii T, Matsumura K (1992) Immunomodulatory effects of ursodeoxycholic acid on immune responses. Hepatology 16: 358–364PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2013

Authors and Affiliations

  • Michael Melter
    • 1
  • Claus Petersen
    • 2
  • Ekkehard Sturm
    • 3
  1. 1.Klinik und Poliklinik für Kinder- und JugendmedizinUniversitätsklinikum RegensburgRegensburgDeutschland
  2. 2.Kinderchirurgische KlinikMedizinische Hochschule HannoverHannoverDeutschland
  3. 3.Universitätsklinik für Kinder- und Jugendmedizin TübingenTübingenDeutschland

Personalised recommendations